Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
N/A
EC/CAS
1310-73-2
Name of the chemical
sodium hydroxide
Concentration
N/A
General Information
Version
2.0
Revision date
2025-07-21
Product name
Levothyroxine Sodium
Chemical name
Levothyroxine Sodium
1.2.1 Relevant identified uses
Treatment of myxedema coma
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals
GHS Information
Signal word
(c) Description of Hazards
Section 2
SECTION 2: Hazards identification
Signal word
(c) Description of Hazards
Hazard statements
Danger Symbol(s), and/or May cause harm to breast-fed children
Precautionary statements
GHS Class Reproductive toxicity. Effects on or via lactation Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. Avoid contact during pregnancy and while using this product. Wash hands thoroughly after handling. Do not eat, drink, smoke when using this product. If exposed or concerned: Get medical advice/attention. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed and overdoses are described in the package insert. Reproductive effects.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection
Potential health effects
Eye: Contact with eyes may cause irritation. Skin: May cause skin irritation. Inhalation: May cause irritation of respiratory tract Ingestion: May cause irritation
2.1 Classification of the substance or mixture
substance or mixture: Reproductive toxicity. Effects on or via lactation. (b) Signal Word, (c) Description of Hazards: Hazard statement(s), Danger
